RPRX Royalty Pharma

Healthcare Pharmaceuticals

Latest news and analysis for Royalty Pharma (RPRX).

1 article | Category: Healthcare

Current Price

$46.21 +0.85 (1.87%)

Market data may be delayed

Price Chart

Loading chart...

All Articles for RPRX

Healthcare | RPRX | 2w ago

Royalty Pharma's Revenue Surge: Vertex's Milestones Set the Tone

Royalty Pharma (RPRX) stands to gain from Vertex Pharmaceuticals' significant revenue growth in cystic fibrosis therapies. Discover the financial implications.

Related Stocks in Healthcare

LLY

Eli Lilly 6 articles

PFE

Pfizer Inc. 3 articles

VRTX

Vertex Pharmaceuticals 3 articles

RARE

Ultragenyx Pharmaceutical 3 articles

NVO

Novo Nordisk 3 articles

HIMS

Hims & Hers Health 3 articles

JNJ

Johnson & Johnson 2 articles

GILD

Gilead Sciences 2 articles

SYK

Stryker Corp. 2 articles

REGN

Regeneron Pharmaceuticals 2 articles

ELV

Elevance Health 2 articles

HUM

Humana Inc. 2 articles

Cookie Notice

RPRX Royalty Pharma

Price Chart

All Articles for RPRX

Royalty Pharma's Revenue Surge: Vertex's Milestones Set the Tone

Related Stocks in Healthcare